Projected Earnings Date: 2024-08-12    (Delayed quote data   2024-08-26)
Last
 1.51
Change
 ⇓ 0.00   (0.00%)
Volume
  120,938
Open
 1.51
High
 1.52
Low
 1.51
8EMA (Daily)
 1.49
40EMA (Daily)
 1.34
50EMA (Daily)
 1.27
STO (Daily)
 68.500
MACD Hist (Daily)
 -0.021
8EMA (Weekly)
 1.387
40EMA (Weekly)
 1.26
50EMA (Weekly)
 1.49
STO (Weekly)
 98.313
MACD Hist (Weekly)
 0.211
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com